Understanding hepatitis B, hepatitis C and HIV among people who inject drugs in South Africa: findings from a three-city cross-sectional survey

Table 5 Associations with HCV serostatus among PWID in three South African cities (n = 943)

	OR	95% CI	P value	aOR	95% CI	P value
Age (≥ 29 years)	1.21	0.93–1.56	0.151	1.00	0.74–1.36	0.995
Male sex	1.03	0.70–1.50	0.889	1.01	0.65–1.56	0.966
Black race	1.13	0.87–1.46	0.373	0.52	0.36–0.74	< 0.001
Pretoria	1.26	1.21–1.32	< 0.001	1.27	1.21–1.34	< 0.001
Living on the street	1.59	1.21–2.09	0.001	1.90	1.38–2.60	< 0.001
Injects ≥ 4 times per day	1.67	1.25–2.19	< 0.001	1.58	1.15–2.16	0.005
Used new needle at last injection	0.70	0.51–0.94	0.020	0.87	10.61–1.23	0.416
Shared needle at last injection	1.06	0.96–1.17	0.254	0.96	0.86–1.07	0.414
Sexually active in last month	0.40	0.31–0.52	< 0.001	0.61	0.42–0.88	0.008
Condom at last penile-vaginal sex	0.48	0.35–0.65	< 0.001	0.85	0.57–1.28	0.432
HIV infection	1.08	0.78–1.49	0.636	1.69	1.15–2.47	0.008

ISSN: 1477-7517